Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 879 | 646 | 1,410 | 11,974 | 7,515 |
| Marketable Securities | 10,491 | 12,513 | 14,007 | N/A | N/A |
| TOTAL | $12,484 | $14,401 | $16,727 | $12,086 | $7,682 |
| Non-Current Assets | |||||
| PPE Net | 52 | 58 | 54 | 11 | 14 |
| Other Non-Current Assets | 9 | 9 | 9 | 9 | 9 |
| TOTAL | $61 | $67 | $63 | $20 | $22 |
| Total Assets | $12,545 | $14,468 | $16,789 | $12,105 | $7,704 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 448 | 567 | 1,366 | 356 | 223 |
| Accrued Expenses | 1,189 | 416 | 281 | 397 | 454 |
| TOTAL | $1,638 | $983 | $1,647 | $753 | $677 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,063 | 565 | 521 | 1,957 | 616 |
| TOTAL | $1,063 | $565 | $521 | $1,957 | $616 |
| Total Liabilities | $2,701 | $1,548 | $2,167 | $2,710 | $1,293 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,471 | 41,421 | 41,421 | 34,754 | 30,742 |
| Common Shares | 42 | 41 | 41 | 35 | 31 |
| Retained earnings | -47,067 | -43,923 | -42,179 | -42,102 | -39,481 |
| TOTAL | $9,844 | $12,920 | $14,622 | $9,395 | $6,411 |
| Total Liabilities And Equity | $12,545 | $14,468 | $16,789 | $12,105 | $7,704 |